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Abstract
Background: Obesity is associated with an impaired ability to switch from fatty acid to glucose oxidation during
the fasted to fed transition, particularly in skeletal muscle. However, whether such metabolic inflexibility is reflected
at the gene transcription level in circulatory mononuclear cells (MNC) is not known.
Methods: The whole-body respiratory quotient (RQ) and transcriptional regulation of genes involved in
carbohydrate and lipid metabolism in MNC were measured during fasting and in response (up to 6 h) to
high-carbohydrate and high-fat meals in nine lean insulin-sensitive and nine obese insulin-resistant men.
Results: Compared to lean subjects, obese subjects had an impaired ability to increase RQ and switch from fatty acid
to glucose oxidation following the high-carbohydrate meal (interaction term P < 0.05). This was accompanied by an
impaired induction of genes involved in oxidative metabolism of glucose in MNC, such as phosphofructokinase (PFK),
pyruvate dehydrogenase kinase 4 (PDK4), peroxisome proliferator-activated receptor alpha (PPARα) and uncoupling
protein 3 (UCP3) and increased expression of genes involved in fatty acid metabolism, such as fatty acid translocase
(FAT/CD36) and fatty acid synthase (FASN) (P < 0.05). On the contrary, there were no differences in the gene expression
profiles between lean and obese subjects following the high-fat meal.
Conclusions: Postprandial expression profiles of genes involved in glucose and fatty acid metabolism in the MNC
reflect the differing metabolic flexibility phenotypes of our cohort of lean and obese individuals. These differences in
metabolic flexibility between the lean and obese are elicited by an acute meal challenge that is rich in carbohydrate
but not fat.
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Background
Normal energy metabolism is characterized by periodic
shifts between glucose and fatty acid oxidation according to
physiological and nutritional status [1, 2]. Impaired ability
for such a switch in fuel oxidation, known as metabolic
inflexibility, has been shown to occur early in the pathogen-
esis of insulin resistance, and is closely associated with
obesity [3–5]. Increasingly, obesity-related cardiometabolic
complications are recognized as disorders linked to meta-
bolic inflexibility [6–11]. Current evidence supports the no-
tion that metabolic flexibility is indeed observed at the level
of gene and protein expression in skeletal muscle tissue
samples, obtained by biopsies [12]. Moreover, physiological
induction or suppression of a wide range of transcripts,
which occurs during the fasting-to-fed transition, is attenu-
ated in models of metabolic disease [13–15].
Circulating mononuclear cells (MNC) can be obtained
in large quantities through routine blood draws, in
contrast to skeletal muscle biopsy which is invasive and
could pose higher risk to the study subjects. A com-
parison of MNC transcriptome and that of different
human tissues demonstrated that over 80 % of gene
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expression is shared and that these gene transcripts in
MNC display changes in the cellular environment [16].
It has been demonstrated that gene transcripts in MNC
can provide an accurate representation of transcriptional
responses of metabolic tissues (i.e. hepatocytes and
adipocytes) to nutrient intake in humans [17–19]. MNCs
have been suggested as an alternative to muscle biopsies
to study mitochondrial dysfunction [20, 21].
In this study, we examined the transcriptional
responses of genes involved in glycolytic, oxidative and
fatty acid metabolism in MNC in response to a single
high-carbohydrate or high-fat meal among individuals
with different metabolic flexibility. We hypothesized that
(1) acute meal challenges of differing composition (high
carbohydrate vs high fat) would have a different propen-
sity to elicit differences in metabolic flexibility between
the lean and obese; and (2) dynamic changes in meta-
bolic gene expression profiles in MNC could reflect the
underlying metabolic flexibility status of individuals.
Methods
Study approval and subjects
This study was approved by the Singapore’s National
Healthcare Group Domain Specific Review Board (DSRB
Ref No: C/2013/00902), and all procedures followed the
Singapore Good Clinical Practice guideline and the princi-
ples of the 2013 Declaration of Helsinki. All subjects
provided written consent before participation in this study.
We recruited a total of 18 normoglycemic (fasting blood
glucose <5.6 mmol/l, no history of diabetes) Chinese men
aged 21–40 years. We excluded subjects who are currently
smoking, with previous or current thyroid disorder, history
of malignancy, hospitalization or surgery during the past
6 months, on treatment for dyslipidemia, use of corticoste-
roids during the past 3 months, or consume alcohol >3
units daily, perform moderate to high intensity physical
activity >5 h per week, or had ≥ 5 % change in their weight
within the past 3 months prior to the study. We also
excluded those who have a first degree relative with Type 2
diabetes. We used the WHO definition for obesity in
Asians to define our lean (18.5 ≤ BMI ≤23 kg/m2) and
obese (BMI ≥27.5 kg/m2) subjects [22]. A Homeostatic
Model Assessment-Insulin Resistance (HOMA-IR) score
of <1.2 mmol/l.mU/L was used to identify insulin-sensitive
lean subjects, and ≥ 2.5 mmol/L.mU/L to identify insulin-
resistant obese subjects.
Experimental design
During the screening visit, subjects’ height, weight, and
waist circumference were measured. Fasting blood was
collected to measure serum insulin, glucose, electrolytes,
and non-esterified fatty acid (NEFA) concentrations, and
lipid profile. Subsequently, eligible subjects were invited
to study visits at the Investigational Medicine Unit
(IMU) on two separate occasions, seven days apart.
Subjects arrived at the IMU at 7:30 AM, after a 10-h over-
night fast. All subjects were advised to refrain from inten-
sive physical activity for 24 h before each visit. An
isocaloric (~600 kcal), isovolumic (~400 ml) liquid mixed
meal, rich in either carbohydrate or fat, was given to the
subjects in random order and to be ingested within 5 min.
The high-carbohydrate and high-fat meals provided
~56 % of total energy from carbohydrate or fat (with a
1:1:1 ratio of saturated, mono- and poly-unsaturated fatty
acids; Additional file 1: Table S1), respectively. Fasting and
postprandial (30, 60, 90, 120, 180, 240, 300, and 360 min)
venous blood samples were collected through an intraven-
ous catheter for the measurement of glucose, insulin, tri-
glycerides and NEFA concentrations. Oxygen consumption
(VO2) and carbon dioxide production (VCO2) were
measured through an open-circuit indirect calorimetry
system using a ventilated hood (Quark CPET,
COSMED®, Italy) for 30 min before the meal and
continuously after the meal for 6 h. Respiratory quo-
tient (RQ) was calculated from VO2 and VCO2 as
follows: RQ = VCO2/VO2.
Biochemical analysis
Plasma glucose and triglyceride concentrations were
measured by using enzymatic and colorimetric methods,
respectively (AU5800, Beckman Coulter Inc., California,
USA). Serum insulin was measured by using a chemilumin-
escence immunoassay (ADVIA Centaur, Siemens Health-
care Diagnostics, Hamburg, Germany). These analyses were
carried out by a laboratory accredited by the College of
American Pathologists. Plasma NEFA was measured at
Mayo Medical Laboratories (Rochester, MN, USA), using an
enzymatic colorimetric method (Cobas® 6000, Roche Diag-
nostics, Indianapolis, USA).
Gene expression
A 9 ml blood sample was collected into tubes containing
EDTA at 0, 120, and 360 min. The blood sample was then
layered over 9 ml of Ficoll-paque Plus (GE Healthcare,
Buckinghamshire, UK) and centrifuged. Phosphate-buffered
saline was used to wash the harvested MNC, followed by
red blood cell lysis (Sigma-Aldrich, St. Louis, MO, USA).
RNeasy Mini Kit (QIAGEN, Netherlands) was used to
isolate total RNA from MNC. High capacity cDNA
Reverse-Transcription Kit (Applied Biosystems, Waltham,
MA, USA) was used to reverse transcribe 500 ng of total
RNA. Real-time reverse transcription–polymerase chain
reaction (RT-PCR) was performed using ViiA 7 Real-Time
PCR System (Applied Biosystems). The PCR mix consisted
of 2 μL (10 ng) cDNA, 5 μL QuantiFast SYBR Green PCR
Master mix (QIAGEN), and 0.1 μL of 100 μmol/L gene-
specific primers (AIT Biotech, Singapore). All the proce-
dures above were performed according to manufacturer’s
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instructions. Available sequences in the NCBI nucleotide
database were used to select primer sequences, using
Primer Express software v3.0.1 (Applied Biosystems)
(Additional file 2: Table S2). At the end of the amplification,
melt curves were analysed to test the specificity of the PCR
products. All samples were run in duplicates and variations
in the threshold cycle (CT) between technical replicates
were within 10 %. All values were normalized to the expres-
sion of a housekeeping gene (GAPDH). The expression of
GAPDH gene was stable and did not show significant
variation across the different time points, meals, and
subject’s phenotype. We determined the ability to switch
from fatty acid to glucose oxidation in MNC using a panel
of genes involved in the regulation of glucose and fatty
acid metabolism i.e. hexokinase (HK), phosphofructoki-
nase (PFK), pyruvate dehydrogenase kinase 4 (PDK4),
peroxisome proliferator-activated receptor alpha (PPARα),
uncoupling protein 3 (UCP3), fatty acid translocase (FAT/
CD36), acetyl Co-A carboxylase 2 (ACC2), fatty acid
synthase (FASN), stearoyl Co-A desaturase (SCD), Carni-
tine palmitoyltransferase 1B (CPT1B), and sterol regula-
tory element -binding protein 1 (SREBP1). Three sets of
samples following the high-carbohydrate meal (2 sets from
lean subjects, 1 set from obese subjects) were excluded
due to insufficient or poor quality of RNA.
Statistical analysis
A sample size of nine subjects in each group was calculated
to provide 80 % power at 5 % significance level to detect
differences between the groups in RQ changes from fasting
to insulin stimulated (postprandial) state following a meal
challenge, as reported previously [3]. Data are shown as
means ± SEM unless otherwise stated. Analyses were
carried out with SPSS version 23.0 for Windows (SPSS Inc.,
Chicago, IL, USA). Fasting gene expression levels before
ingesting the two experimental meals were tested by paired
sample t-tests within each group of subjects, to verify there
were no differences at baseline between two visits. Differ-
ences for averaged values for each group were tested by
independent sample t-test. The incremental area under the
curve (iAUC) was computed using the trapezoidal method.
Repeated-measures ANOVA was used to evaluate differ-
ences in the RQ esponse to the meal by group and time.
We performed a linear mixed model to analyse MNC gene
expression differences between groups by meals. Fold-
change from baseline in MNC gene expression of interest
was entered as the dependent variable. Time and group
were entered as factors in the model. We introduced inter-
action term time × subjects’ group to examine whether the
postprandial responses for the gene of interest differed
between subjects’ groups. Differences in fold-changes in
MNC gene expression at a single time point (120 min or
360 min) between the two groups were tested by independ-
ent sample t-test. Statistical significance was set at P < 0.05.
Results
Baseline characteristics
Obese subjects were older, and had greater waist circum-
ference, HOMA-IR, fasting plasma insulin and triglyceride
concentrations compared to lean subjects. In contrast,
lean subjects had higher fasting HDL-cholesterol concen-
tration. Fasting glucose, total and LDL-cholesterol, and
NEFA concentrations were not different between lean and
obese subjects (Table 1).
Fasting expression levels of all investigated genes were
averaged, and we observed no significant variation in the
fasting expression of all genes between visits. The fasting
expression levels of all genes examined, except PDK4,
trended lower in obese compared to lean subjects but
reached statistical significance only for HK, PFK, PPARα,
FASN, and SCD (Additional file 3: Figure S1). The
fasting expression level of PDK4 trended higher in obese
subjects compared to lean subjects although it did not
reach statistical significance.
Glucose, insulin, triglycerides and NEFA trajectories
following meals
Overall, the postprandial responses for insulin and tri-
glycerides were greater in obese than lean subjects
(Table 2) while there were no differences between obese
and lean subjects for the postprandial glucose and NEFA






P Adjusted P *
Age (years) 23.2 ± 0.2 28.6 ± 1.4 0.002
BMI (kg/m2) 22.0 ± 0.2 30.2 ± 0.8 <0.001 <0.001
Waist Circumference
(cm)
79.9 ± 0.5 100.8 ± 1.0 <0.001 <0.001
Fasting Blood
Glucose (mmol/l)
4.33 ± 0.05 4.68 ± 0.12 0.026 0.459
Fasting Serum
Insulin (mU/l)
4.31 ± 0.52 21.04 ± 2.27 <0.001 <0.001
Fasting Total
Cholesterol (mmol/l)
5.09 ± 0.27 5.28 ± 0.40 0.697 0.791
Fasting LDL-
Cholesterol (mmol/l)
3.09 ± 0.29 3.20 ± 0.35 0.823 0.730
Fasting HDL-
Cholesterol (mmol/l)
1.71 ± 0.08 1.19 ± 0.06 0.001 0.005
Fasting Triglyceride
(mmol/l)
0.62 ± 0.07 1.98 ± 0.24 <0.001 0.007
Fasting NEFA
(mmol/l)a
0.41 ± 0.04 0.49 ± 0.03 0.037 0.392
HOMA-IR 0.83 ± 0.10 4.34 ± 0.41 <0.001 <0.001
Fasting RQ 0.79 ± 0.01 0.78 ± 0.01 0.784 0.463
Data are presented as the means ± SEM; * age-adjusted, alog transformed
comparison of the mean; BMI body mass index, LDL low-density lipoprotein,
HDL high-density lipoprotein, HOMA-IR homeostasis model assessment for
insulin resistance, NEFA nonesterified fatty acids, RQ respiratory quotient
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responses. Table 2 shows the iAUC of plasma glucose,
insulin, triglycerides, and NEFA in response to both
meals. In obese subjects, the iAUCs for insulin and
triglycerides were greater compared to lean subjects
in response to both high-carbohydrate (P < 0.001 and P =
0.067, respectively) and high-fat (P = 0.019 and P = 0.004,
respectively) meals. No significant differences between
lean and obese subjects were found in the iAUCs for
glucose and NEFA in response to either meal challenge.
Changes in RQ following meals
There was no statistical difference for the fasting RQ
between lean and obese subjects (Fig. 1). The postpran-
dial RQ changes were significant after a high-
carbohydrate meal in both lean and obese subjects
(time effect P < 0.001), but the mean postprandial RQ
from 0 to 240 min during the postprandial period was
significantly higher in the lean compared to obese sub-
jects (group effect P < 0.05). The 0–240 min postpran-
dial RQ trajectories were significantly different between
lean and obese subjects (interaction term time x group P
< 0.05).
For the high-fat meal, there were no statistical differ-
ences in the mean postprandial RQ change throughout
the postprandial period between lean and obese subjects.
Changes in metabolic gene expression profiles in MNCs
following acute meal challenges
In response to the high-carbohydrate meal, mean post-
prandial fold changes for expression of PFK, PDK4,
PPARα, UCP3 (Fig. 2a), and ACC2 (Fig. 3a) were signifi-
cantly different between groups (P < 0.05). Obese subjects
had a lower increase in PFK (at 2 h), PPARα, UCP3, and
ACC2 (at 6 h), and a lower decrease in PDK4 (at 2 h) than
lean subjects (interaction term P < 0.05). In contrast,
mean postprandial fold changes for gene expression of
FAT/CD36 and FASN at 6 h were higher in obese com-
pared with lean subjects (Fig. 3a).
After the high-fat meal, no significant differences in
the metabolic gene expression profiles in MNCs were
seen between lean and obese subjects (Figs. 2b and 3b).
Table 2 Postprandial serum insulin, glucose, triglyceride, and NEFA responses to the test meals
HC meal P HF meal P
Insulin iAUC0-360 min
(mU. min. L-1)
Obese 20540 ± 2575 0.001 10508 ± 1846 0.019
Lean 8374 ± 867 5378 ± 703
Glucose iAUC0-360 min
(mmol. min. L-1)
Obese 257 ± 40 0.376 147 ± 9 0.685
Lean 207 ± 37 161 ± 32
Triglyceride iAUC0-360 min
(mmol. min. L-1)
Obese 204.0 ± 59.3 0.067 373.3 ± 77.7 0.004
Lean 79.0 ± 23.0 104.9 ± 16.2
NEFA iAUC0-360 min
(mmol. min. L-1)
Obese -59.33 ± 13.66 0.969 -28.90 ± 20.27 0.874
Lean -58.40 ± 19.26 -33.30 ± 18.32
Data are presented as the mean incremental area under the curve ± SEM; n = 9 for each group. HC high-carbohydrate, HF high-fat; Statistical differences are based
on repeated-measures ANOVA
Fig. 1 Postprandial changes in respiratory quotient between lean and obese subjects by meals. a high-carbohydrate meal (0–240 min: P
group = 0.045, time <0.001 and time × group = 0.047; 240–360 min: P group = 0.053, time <0.001 and time × group = 0.099); b high-fat meal
(0–240 min: P group = 0.734, time = 0.050 and time × group = 0.482; 240–360 min: P group = 0.927, time = 0.293 and time × group = 0.802).
Lean —, ●; obese ——, ○; * P < 0.05
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Discussion
A meal rich in carbohydrate, but not fat was associated
with a blunted response in switching from fat to glucose
oxidation in obese compared with lean individuals, as
indicated by the postprandial RQ change data from
whole-body indirect calorimetry. This impaired ability to
switch substrate metabolism from fasting to fed state in
obese subjects was also reflected in the glycolytic, oxida-
tive and lipid metabolism gene expression profiles in cir-
culating MNC. The lean, being more metabolically
flexible, exhibited a sharp induction or suppression of a
wide range of metabolic gene transcripts during the
Fig. 2 Fold changes from baseline in the expression of genes involved in glycolytic pathway and oxidative metabolism in MNC after ingesting a (a)
high-carbohydrate or a (b) high-fat meal between lean and obese subjects. Significant differential responses, as analysed by linear mixed model, were
found after high-carbohydrate meal in expression of: PFK (P group = 0.032, and time × group =0.032), PDK4 (P group = 0.002, and time × group =0.002),
PPARα (P group =0.024, and time × group =0.014), and UCP3 (P group =0.025, and time × group =0.012). Significant differences at a single time point
(120 min or 360 min) between the two groups, as tested by independent sample t-test, have been presented in the figure. Data presented as mean ±
SEM. Lean—, ●; obese——, ○; * P < 0.05
Fig. 3 Fold changes from baseline in expression of genes involved in fatty acid uptake and metabolism in MNC after ingesting a
(a) high-carbohydrate or a (b) high-fat meal between lean and obese subjects. Significant differential responses, as analysed by linear mixed model, were
found after high-carbohydrate meal in expression of: FAT/CD36 (P group = 0.040 and time × group =0.040), FASN (P group = 0.083, and time
× group =0.083), and ACC2 (P group = 0.033, and time × group =0.033). Significant differences at a single time point (120 min or 360 min)
between the two groups, as tested by independent sample t-test, have been presented in the figure. Data presented as mean ± SEM. Lean
—, ●; obese ——, ○; * P < 0.05
Baig et al. Nutrition & Metabolism  (2016) 13:74 Page 5 of 8
fasted-to-fed transition in the MNC, but these responses
were attenuated in obese-derived MNC.
Skeletal muscle explants have been conventionally
used to study metabolic gene transcripts [13, 14, 23–25].
Data from these studies demonstrate perturbation in
metabolic gene expressions in skeletal muscle explants
derived from individuals with varying degrees of meta-
bolic health [12–14]. For example, skeletal muscle
mRNA expression levels of fatty acid metabolism genes
at basal state have been shown to reflect metabolic
dysregulation associated with insulin resistance [14].
Also, in a study on individuals with or without heredity
of type 2 diabetes challenged with a single high-
carbohydrate or high-fat meal, skeletal muscle metabolic
gene expression profile was shown to correlate well with
metabolic flexibility [13]. However, skeletal muscle
biopsy is an invasive procedure that can pose significant
risk to the study subject. In patients with high risk of
infection (for example patients with type 2 diabetes) or
bleeding tendency (patients on anticoagulants), skeletal
muscle biopsies may not be feasible [26]. Here, we
showed that MNC could be used as an alternative to
muscle biopsy explants to interrogate dynamic changes
in metabolic gene expression profiles.
In this study, we showed in obese-derived MNC, an
impaired ability to upregulate the expression of PFK and
UCP3 and downregulate the expression of PDK4 in
response to a high-carbohydrate meal. PDK4 phosphory-
lates and inhibits PDK activity, leading to reduced conver-
sion of pyruvate to acetyl-CoA, impaired glucose oxidation
and increased fatty acid oxidation, a phenomenon seen in
insulin-resistant individuals [27]. Hence, transcriptional
changes in these genes might be a reflection of metabolic
inflexibility in metabolic tissues. We further observed that
fatty acid uptake and synthesis genes (i.e. FAT/CD36 and
FASN), but not genes regulating β-oxidation (i.e. PPARα,
ACC2, and CPT1B) were upregulated in obese vs. lean
subjects following the high-carbohydrate meal. This likely
reflects an overall higher propensity for lipogenesis (fatty
acid synthesis and uptake) over lipid oxidation in obese
subjects. Consistent with our findings, increased expression
of these lipogenic genes has also been reported previously
in skeletal muscle of insulin-resistant individuals [14, 25].
We also showed that macronutrient composition of a
test meal is important when considering a study on
metabolic flexibility, whether measured by RQ changes
or assessed by examining cellular gene expressions pro-
files. In this study, we showed that a high-carbohydrate
test meal can elicit the metabolic inflexibility phenotype
in obese compared to lean subjects. But such metabolic
traits would not be demonstrable if we use a high-fat
test meal. Consistent with the metabolic trait found in
this study, we also found greater pro-inflammatory post-
prandial responses to a high-carbohydrate, but not to a
high-fat meal in obese compared with lean subjects
(manuscript under review). Taken together, a single high-
carbohydrate meal can elicit more adverse metabolic
effects as compared to a high-fat meal (with a balanced
proportion of SFA, PUFA, and MUFA) among obese
individuals. The cumulative adverse metabolic effects
from high-carbohydrate meals may predispose them to
higher cardiometabolic disorders in the long term. In a
previous report, metabolic inflexibility phenotype in indi-
viduals with heredity of type 2 diabetes was shown to be
elicited by an acute meal challenge that is rich in fat, but
not carbohydrate [13]. Differences in meal composition
(76 % of energy from fat or carbohydrate, as opposed to
56 % in our study) and subject characteristics (obese with
family history of type 2 diabetes, as opposed to no family
history of type 2 diabetes in our study) could explain the
discrepant results.
There are several limitations to this study. Despite having
a well characterized cohort of lean insulin-sensitive and
obese insulin-resistant individuals, our sample size was
relatively small. Still, our study was adequately powered to
detect significant differences in RQ and transcriptional
changes in genes involved in substrate oxidation. We only
studied Chinese men, and future study will be required to
validate these results in a larger cohort consisting of other
ethnic groups as well as in women. Lastly, gene and protein
expression profiling in the skeletal muscle biopsies and
circulating MNC concurrently derived from the same
subjects would be ideal to validate our findings.
Conclusions
In conclusion, we found that obesity-associated metabolic
inflexibility is demonstrable in the circulating MNC at the
level of transcription of genes involved in lipid and carbohy-
drate metabolism. Importantly, adverse metabolic responses
were more pronounced following a high-carbohydrate, but
not a high-fat acute meal challenge. Our study suggests that
macronutrient composition should be taken into consider-
ation in nutritional intervention strategies for obese individ-
uals to reduce weight or to improve metabolic profiles.
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